Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia

NCT00664664 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

744

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Insomnia

Interventions

DRUG: APD125
DRUG: APD125
DRUG: Placebo

Sponsor

Arena Pharmaceuticals